Active Pharma Ingredients (APIs)
JPN Pharma is a global leader in the production of large-volume generic Active Pharmaceutical Ingredients (APIs), committed to upholding environmental safety and sustainability at every stage. Our facilities boast prestigious EDQM (European Directorate for the Quality of Medicines) and WHO-GMP (World Health Organization - Good Manufacturing Practices) approvals, underscoring our expertise in handling hazardous chemicals and executing complex reactions with meticulous precision. Supported by a dedicated R&D setup and stringent QA/QC practices, we ensure uncompromising quality across varied batch sizes and reactor volumes ranging from 5 to 8000 liters.
At JPN Pharma, sustainability is ingrained in our operational ethos. We employ environmentally responsible production methods and prioritize the use of clean fuel in our boiler operations. Our advanced equipment includes the Agitated Nutsche Filter Dryer (ANFD) and Rotary Vacuum Paddle Dryer, enabling safe and efficient production, particularly for temperature-sensitive products. Managed by JPN LLP, our Zero Liquid Discharge facility exemplifies our commitment to minimizing environmental impact.
Trusted by esteemed pharmaceutical leaders like Cipla, Glenmark, Zydus, and Abbott, JPN Pharma specializes in manufacturing APIs on a significant scale. Situated in Maharashtra, our GMP and FDA-approved facilities are dedicated to producing essential molecules that play a pivotal role in global healthcare solutions.
Our APIs are used across various therapeutic categories, including:
Topical antimicrobials
Cardiovascular treatments
Hypertension and heart failure management
Bone health
Benign prostatic hyperplasia
Anticonvulsants
Dementia care
JPN Pharma continues to lead the industry with a steadfast commitment to
quality, sustainability and innovation.
Name of Product :- BISACODYL |
DMF |
SR. NO. | CRITERIA | SPECIFICATION |
1 | Description | White to off white crystalline powder. |
2 | Solubility | Soluble in chloroform and in benzene; sparingly soluble in alcohol and in methanol; slightly soluble in ether; practically insoluble in water |
3 | Identification : A. By Infrared Absorption |
should concordant with the infrared spectrum of the Bisacodyl working standard obtained in Same manner. B. The retention time of the major peak in the sample solution corresponds to that of the standard solution as obtained in |
4 | Assay By HPLC (On Dried Basis) | Not less than 98.0% and not more than 102.0 % |
5 | Residue on ignition | Not more than 0.1% |
6 | Related substances (By HPLC) Impurity A Impurity B Impurity C Specified Unidentified Impurity 1 Impurity E Specified Unidentified Impurity 2 Any individual unspecified impurity Total impurity |
Not more than 0.15% Not more than 0.50% Not more than 0.20% Not more than 0.50% Not more than 0.30% Not more than 0.10% Not more than 1.0% |
7 | Loss on drying (105°C for 2 hrs) | Not more than 0.5% |
